Treatment of hepatitis C infection in patients with renal disease

Jorge M. Diego, David Roth

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Hepatitis C virus infects 20-40% of the end-stage renal disease population, and has been associated with essential mixed cryoglobulinemia and several forms of immune-complex glomerulonephritis. Overall, treatment with interferon alpha has been disappointing, although certain situations may benefit from dosing regimens that differ in the amount of drug and duration of treatment from the conventional interferon doses currently recommended for non-renal patients.

Original languageEnglish (US)
Pages (from-to)557-562
Number of pages6
JournalCurrent Opinion in Nephrology and Hypertension
Issue number5
StatePublished - Oct 28 1998

ASJC Scopus subject areas

  • Internal Medicine
  • Nephrology


Dive into the research topics of 'Treatment of hepatitis C infection in patients with renal disease'. Together they form a unique fingerprint.

Cite this